Balyasny Asset Management
MBII

Balyasny Asset Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Balyasny Asset Management’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-23,350
Closed -$27K – 3477
2022
Q2 		$27K Buy
+23,350
New +$24.4K ﹤0.01% 2446

Balyasny Asset Management's MBII Position: Q3 2022 in Review

Balyasny Asset Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 23,350 shares — an estimated $27K sold.

Balyasny Asset Management first reported a position in MBII in Q2 2022 and held it in 1 quarter. The position peaked at $27K in Q2 2022. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

  • Balyasny Asset Management reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 23,350 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $27K.
  • Balyasny Asset Management first reported a position in Marrone Bio Innovations, Inc. in Q2 2022 and held it in 1 quarter.
  • Balyasny Asset Management's Marrone Bio Innovations, Inc. position peaked at $27K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.